Stay informed with the latest updates for the inheritable blood disorders community.

Court Issues Final Judgement in Shire/Roche Patent Lawsuit
Court Issues Final Judgement in Shire/Roche Patent Lawsuit
Medical
Gene Therapy with Transplanted Cells Shows Promise in Hemophilia A Mice
Gene Therapy with Transplanted Cells Shows Promise in Hemophilia A Mice
13 Athletes Run with Team NHF in the 2019 NYC Half Marathon
13 Athletes Run with Team NHF in the 2019 NYC Half Marathon
Takeda Completes Acquisition of Shire
Takeda Completes Acquisition of Shire
Honoring Linda Gammage
Honoring Linda Gammage
7 Reasons to Support NHF
7 Reasons to Support NHF
Industry
Sangamo Announces First Patient Treated in Hemophilia B Gene Therapy Trial
Sangamo Announces First Patient Treated in Hemophilia B Gene Therapy Trial…
NHF Statement on Texas vs. United States Lawsuit
NHF Statement on Texas vs. United States Lawsuit
Medical
Results of Bayer's PROTECT VIII Extension Study Announced
Results of Bayer's PROTECT VIII Extension Study Announced
Bioverativ and Sobi Release Long-Term Study Results for Extended Half-Life Therapies
Bioverativ and Sobi Release Long-Term Study Results for Extended…
NHF’s Current Research Grant Cycle
NHF’s Current Research Grant Cycle
Medical
Two New MASAC Documents Issued
Two New MASAC Documents Issued
Medical
Inhibitor Chapter Updated in Nurses’ Guide to Bleeding Disorders
Inhibitor Chapter Updated in Nurses’ Guide to Bleeding Disorders
NBDF & Community
NHF 70th: Give Where You Live
NHF 70th: Give Where You Live
Industry
uniQure Announces Initial Data Showing Positive Early Results from Hemophilia B Gene Therapy
uniQure Announces Initial Data Showing Positive Early…